This immature entity was highly reminiscent of immunophenotypically defined patients with ETP-ALL (1, 23), and about half of the cases in the immature subtype had MEF2C-activating rearrangements (5). This evidence concerns the gene MEF2C and acute lymphoblastic leukemia.